Abstracts tagged "biomarkers and magnetic resonance imaging (MRI)"

Abstract Number: 1885 • 2019 ACR/ARP Annual Meeting
A Search to the Target Tissue in Which RA-specific Inflammation Starts: A Detailed MRI Study to Improve Identification of RA-specific Features in the Phase of Clinically Suspect Arthralgia
Xanthe ME Matthijssen¹, Fenne Wouters ², Debbie Boeters ², Aleid Boer ², Yousra Dakkak ², Ellis Niemantsverdriet ² and Annette van der Helm-van Mil ³, ¹Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, ²Leiden University Medical Center, Leiden, Netherlands, ³LUMC, Leiden, Zuid-Holland, Netherlands
Background/Purpose: Based on a unique cohort of clinically suspect arthralgia (CSA) patients, we analysed which combinations of MRI-features at onset were predictive for Rheumatoid Arthritis…
Abstract Number: 1436 • 2013 ACR/ARHP Annual Meeting
Early Changes In a Multi-Biomarker Disease Activity Score After Starting Adalimumab Treatment Predict Change In MRI Inflammation At 6 Months
Simon Krabbe¹, R.J. Bolce², Cecilie Heegaard Brahe³, Uffe Møller Døhn³, Scott Cruickshank⁴, Bo J. Ejbjerg⁵, Merete L. Hetland³, E.H. Sasso², D. Chernoff⁶, Michael Sejer Hansen⁷, Lene Surland Knudsen⁸, Annette Hansen⁹, Ole Rintek Madsen⁹, Maria Hasselquist¹⁰, Jakob M. Møller¹¹ and Mikkel Østergaard³, ¹Department of Rheumatology, Copenhagen University Hospital Glostrup, Copenhagen, Denmark, ²Crescendo Bioscience Inc., South San Francisco, CA, ³Copenhagen University Hospital Glostrup, Copenhagen, Denmark, ⁴Scott Cruickshank and Associates, Inc., Santa Barbara, CA, ⁵Slagelse Sygehus, Slagelse, Denmark, ⁶Crescendo Bioscience, Inc., South San Francisco, CA, ⁷Gildhøj Privathospital, Copenhagen, Denmark, ⁸Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark, ⁹Copenhagen University Hospital Gentofte, Copenhagen, Denmark, ¹⁰Copenhagen University Hospital Herlev, Copenhagen, Denmark, ¹¹Department of Radiology, Copenhagen University Hospital Herlev, Copenhagen, Denmark
Background/Purpose: A multi-biomarker disease activity (MBDA) score has been validated as a measure of disease activity in rheumatoid arthritis. This study aimed to see if…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].